Sign in
4

Changes in Ownership

Inmune Bio Inc. Filed Acc 0001213900-25-117302

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ganjei James Kelly · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-01 Grant or award : show line 1 in the form Option (right to buy) +150,000 150,000 D
Loading xslF345X05/ownership.xml…